A Handy tool to Rank Anti-Cancer Synergistic drugs

H-RACS is designed to predict synergistic drug combinations based on drug features and basal expression profiling of cancer context. The advantages of H-RACS lie in 1) excellent performance with minimum data input compared to peers; 2) abundant cancer context built-in covering 928 cell lines of 24 cancers; 3) unique and outstanding extendibility to new drug combinations and new cell lines.